T. Rowe Price Associates’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $61.7M | Sell |
1,865,977
-127,919
| -6% | -$4.23M | 0.01% | 680 |
|
2025
Q1 | $80.1M | Sell |
1,993,896
-631,185
| -24% | -$25.4M | 0.01% | 594 |
|
2024
Q4 | $123M | Sell |
2,625,081
-539,864
| -17% | -$25.4M | 0.01% | 528 |
|
2024
Q3 | $167M | Buy |
3,164,945
+806,602
| +34% | +$42.6M | 0.02% | 468 |
|
2024
Q2 | $128M | Sell |
2,358,343
-572,605
| -20% | -$31M | 0.02% | 493 |
|
2024
Q1 | $205M | Sell |
2,930,948
-313,302
| -10% | -$22M | 0.03% | 416 |
|
2023
Q4 | $271M | Buy |
3,244,250
+2,232,623
| +221% | +$186M | 0.04% | 358 |
|
2023
Q3 | $29.8M | Sell |
1,011,627
-73,686
| -7% | -$2.17M | ﹤0.01% | 819 |
|
2023
Q2 | $35.4M | Sell |
1,085,313
-86,716
| -7% | -$2.83M | ﹤0.01% | 797 |
|
2023
Q1 | $41.2M | Buy |
1,172,029
+64,168
| +6% | +$2.26M | 0.01% | 733 |
|
2022
Q4 | $50.8M | Buy |
1,107,861
+14,414
| +1% | +$660K | 0.01% | 657 |
|
2022
Q3 | $53M | Buy |
1,093,447
+595,708
| +120% | +$28.9M | 0.01% | 630 |
|
2022
Q2 | $19.6M | Buy |
497,739
+35,256
| +8% | +$1.39M | ﹤0.01% | 1167 |
|
2022
Q1 | $17M | Buy |
462,483
+313,044
| +209% | +$11.5M | ﹤0.01% | 1266 |
|
2021
Q4 | $6.81M | Buy |
149,439
+119,982
| +407% | +$5.47M | ﹤0.01% | 1462 |
|
2021
Q3 | $1.05M | Buy |
29,457
+1,016
| +4% | +$36.3K | ﹤0.01% | 2035 |
|
2021
Q2 | $563K | Buy |
28,441
+1,261
| +5% | +$25K | ﹤0.01% | 2328 |
|
2021
Q1 | $632K | Buy |
27,180
+3,654
| +16% | +$85K | ﹤0.01% | 2247 |
|
2020
Q4 | $489K | Sell |
23,526
-636,628
| -96% | -$13.2M | ﹤0.01% | 2246 |
|
2020
Q3 | $14.3M | Buy |
+660,154
| New | +$14.3M | ﹤0.01% | 1219 |
|
2018
Q1 | – | Sell |
-427,148
| Closed | -$3.48M | – | 2544 |
|
2017
Q4 | $3.48M | Buy |
427,148
+1,890
| +0.4% | +$15.4K | ﹤0.01% | 1456 |
|
2017
Q3 | $6.17M | Buy |
+425,258
| New | +$6.17M | ﹤0.01% | 1394 |
|
2013
Q4 | – | Sell |
-1,431,573
| Closed | -$10.9M | – | 2490 |
|
2013
Q3 | $10.9M | Sell |
1,431,573
-42,285
| -3% | -$321K | ﹤0.01% | 1249 |
|
2013
Q2 | $17.1M | Buy |
+1,473,858
| New | +$17.1M | ﹤0.01% | 1109 |
|